170714 ⎘
Assays, e.g. immunoassays or enzyme assays, involving lipids; Phospholipids, i.e. phosphoglycerides Glycophospholipids, e.g. phosphatidyl inositol
COMPOSITIONS AND METHODS FOR TREHALOSE PHOSPHOLIPIDS
#2Diagnostic signature
#3QUANTITATIVE LIPIDOMIC ANALYSIS, METHODS AND USES THEREOF
#4DEVICE FOR ONLINE RAPID PRETREATMENT MASS SPECTROMETRY OF MULTI-CELL OR SINGLE-CELL SAMPLE AND APPLICATION THEREOF
#5Application of Lipid Biomarkers in Diagnosis and Early Warning of Fatty Liver in Periparturient Dairy Cows
#6USE OF THE EMM ANTIGEN AS A BIOMARKER OF INHERITED GPI DEFICIENCIES
#7DETECTION OF PHOSPHOINOSITIDES IN BLOOD CELLS AS A BIOMARKER FOR ALPHA SYNUCLEIN ASSOCIATED PATHOLOGIES AND A METHOD OF TREATMENT OF PARKINSON'S DISEASE AND THE RELATED NEURODEGENERATIONS
#8EXTRACELLULAR VESICLE PURIFICATION MATERIAL AND PURIFICATION METHOD
#9A detection method for detecting an oxidized LDL/Beta2GPI complex and a detection kit therefor
#10STRATIFICATION BY SEX AND APOE GENOTYPE IDENTIFIES METABOLIC HETEROGENEITY IN ALZHEIMER'S DISEASE
#11Biomarkers of Breast and Lung Cancer
#12NOVEL COMPOSITIONS AND METHODS FOR TREHALOSE PHOSPHOLIPIDS
#13Lipidomic biomarkers for identification of high-risk coronary artery disease patients
#14Method and associated device for rapid detection of target biomolecules with enhanced sensitivity
#15METHOD FOR EVALUATION OF DRUG EFFICACY OF A MEDICINE HAVING A THERAPEUTIC OR PREVENTIVE EFFECT AGAINST A DISEASE RELATED TO EL ACTIVITY AND A METHOD FOR SCREENING AN INHIBITOR OF EL ACTIVITY
#16Lipidomic biomarkers for identification of high-risk coronary artery disease patients
#17METHOD FOR STABILIZING GLYCEROPHOSPHOLIPIDS AND REAGENTS USING SAME
#18Method and associated device for rapid detection of target biomolecules with enhanced sensitivity
#19DIAGNOSTIC MARKER FOR CORONARY ARTERY DISEASE
#20Biomarkers of Breast and Lung Cancer
#21METHOD FOR STABILIZING GLYCEROPHOSPHOLIPIDS AND REAGENTS USING SAME
#22Lipidomic biomarkers for identification of high-risk coronary artery disease patients
#23PIP2 AS A MARKER FOR HDL FUNCTION AND CARDIOVASCULAR DISEASE RISK
#24METHODS AND PRODUCTS FOR LABELLING LIPIDS
#25METHOD FOR EVALUATION OF DRUG EFFICACY OF A MEDICINE HAVING A THERAPEUTIC OR PREVENTIVE EFFECT AGAINST A DISEASE RELATED TO EL ACTIVITY AND A METHOD FOR SCREENING AN INHIBITOR OF EL ACTIVITY
#26Use of phosphatidylinositol phosphate-binding material for apoptosis detection
#27Lipidomic biomarkers for identification of high-risk coronary artery disease patients
#28Method for evaluation of drug efficacy of a medicine having a therapeutic or preventive effect against a disease related to EL activity and a method for screening an inhibitor of EL activity
#29PC-O 40:1 as a biomarker for healthy aging
#30PHYTOPHTHORA PHOSPHOLIPASE C
#31METHOD FOR STABILIZING GLYCEROPHOSPHOLIPIDS AND REAGENTS USING SAME
#32METHOD FOR STABILIZING GLYCEROPHOSPHOLIPIDS AND REAGENTS USING SAME
#33Compositions and methods for quantitatively monitoring lipids
#34Novel Assay for Inositol Phosphorylceramide Synthase Activity
#35METHODS FOR IDENTIFYING MODULATORS OF LIFESPAN AND RESISTANCE TO OXIDATIVE STRESS
#36Bacterial protein phosphoinositide probes and effectors
#37Assay for inositol phosphorylceramide synthase activity
#38Novel cancer marker and uses therefor in the diagnosis of cancer